ArriVent BioPharma, Inc. - 10-Q Filing

ArriVent BioPharma reports Q3 2026 financial results and details ongoing collaborative arrangements with Shanghai Allist, Lepu Biopharma, and Alphamab.

3 articles from 1 source · updated November 10, 2026, 12:35 UTC

Coverage

• Arbutus Biopharma Corp - 10-Q Filing SEC EDGAR · November 10, 2026, 12:34 UTC
• Arbutus Biopharma Corp - 8-K Filing SEC EDGAR · November 10, 2026, 12:31 UTC
• ArriVent BioPharma, Inc. - 10-Q Filing SEC EDGAR · November 9, 2026, 21:21 UTC